Who
Fred B. Davenport Jr.
Director
Company insider
Files Form 4 as: Director, Medpace Holdings; President, Pharmaceutical Product Development.
In numbers
- Trades disclosed
- 150
- Buys
- 1
- Sells
- 10
- Bought
- $73K
- Sold
- $24.1M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 14 Feb 2006
- Last trade
- 19 Aug 2026
- Last filed
- 21 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Code M | $255K1,903 at $133.87 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Code M | $325K3,858 at $84.36 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Code M | $300K1,822 at $164.68 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,903 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code M | —3,858 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,822 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $4.4M7,283 at $606.15 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,903 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code M | —3,858 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,822 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Code M | $255K1,903 at $133.87 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Code M | $325K3,858 at $84.36 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Code M | $300K1,822 at $164.68 | filing |
| 19 Aug 2026filed 21 Aug 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $4.4M7,283 at $606.15 | filing |
| 15 May 2026filed 18 May 2026 | MEDP Medpace Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,110 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | MEDP Medpace Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,110 at $0.00 | filing |
| 30 Oct 2025filed 3 Nov 2025 | MEDP Medpace Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code M | —6,472 at $0.00 | filing |
| 30 Oct 2025filed 3 Nov 2025 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Code M | $356K6,472 at $54.99 | filing |
| 30 Oct 2025filed 3 Nov 2025 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $3.5M5,972 at $581.88 | filing |
| 16 May 2025filed 20 May 2025 | MEDP Medpace Holdingsoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,224 at $0.00 | filing |
News
Medpace (NASDAQ:MEDP) Reaches New 1-Year High Following Strong EarningsMEDP · dailypolitical.com · 22 Oct 2026Medpace Holdings, Inc. Profit Climbs In Q3MEDP · finanzen.ch · 22 Oct 2026Medpace Stock Slips Despite Solid Report; Where Are The 'Holes?'MEDP · investors.com · 22 Oct 2026
0 headlines in the last 90 days name Fred B. Davenport Jr.; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.